Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.75 GBX | -4.55% | +200.00% | +9.38% |
07-04 | Crism Therapeutics Affirms Plan to File Clinical Trial Application for Lead Product in H2 | MT |
07-03 | Crism flags contract talks, reacts to share price surge | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+9.38% | 1.76M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- CRTX Stock
- News CRISM Therapeutics Corporation
- Crism Therapeutics Affirms Plan to File Clinical Trial Application for Lead Product in H2